Effect of Tocilizumab on “ventilator free days” composite outcome in SARS-CoV-2 patients. A retrospective competing risk analysis
Ahmed F. Mady, Basheer Abdulrahman, Omar E. Ramadan, Shahzad A. Mumtaz, Mohammed A. Al-Odat, Ahmed Kuhail, Rehab Altoraifi, Rayan Alshae, Abdulrahman M. Alharthy, Dimitrios Karakitsos, Waleed Th. Aletreby
doi: https://doi.org/10.1101/2021.04.01.21254794
Ahmed F. Mady
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
2Anesthesia Department, Faculty of Medicine, Tanta University, Tanta, Egypt
Basheer Abdulrahman
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Omar E. Ramadan
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
3Anesthesia Department, Faculty of Medicine, Ain-Shams University, Cairo, Egypt
Shahzad A. Mumtaz
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Mohammed A. Al-Odat
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Ahmed Kuhail
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Rehab Altoraifi
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Rayan Alshae
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Abdulrahman M. Alharthy
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Dimitrios Karakitsos
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
4Department of Medicine, South Carolina University School of Medicine, Columbia, SC, USA
5Critical Care Department, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
Waleed Th. Aletreby
1Critical Care Department, King Saud Medical City, Riyadh, Saudi Arabia
Data Availability
Data may be requested from the corresponding author by e-mail.
Posted April 07, 2021.
Effect of Tocilizumab on “ventilator free days” composite outcome in SARS-CoV-2 patients. A retrospective competing risk analysis
Ahmed F. Mady, Basheer Abdulrahman, Omar E. Ramadan, Shahzad A. Mumtaz, Mohammed A. Al-Odat, Ahmed Kuhail, Rehab Altoraifi, Rayan Alshae, Abdulrahman M. Alharthy, Dimitrios Karakitsos, Waleed Th. Aletreby
medRxiv 2021.04.01.21254794; doi: https://doi.org/10.1101/2021.04.01.21254794
Effect of Tocilizumab on “ventilator free days” composite outcome in SARS-CoV-2 patients. A retrospective competing risk analysis
Ahmed F. Mady, Basheer Abdulrahman, Omar E. Ramadan, Shahzad A. Mumtaz, Mohammed A. Al-Odat, Ahmed Kuhail, Rehab Altoraifi, Rayan Alshae, Abdulrahman M. Alharthy, Dimitrios Karakitsos, Waleed Th. Aletreby
medRxiv 2021.04.01.21254794; doi: https://doi.org/10.1101/2021.04.01.21254794
Subject Area
Subject Areas
- Addiction Medicine (313)
- Allergy and Immunology (616)
- Anesthesia (158)
- Cardiovascular Medicine (2257)
- Dermatology (201)
- Emergency Medicine (368)
- Epidemiology (11549)
- Forensic Medicine (10)
- Gastroenterology (676)
- Genetic and Genomic Medicine (3541)
- Geriatric Medicine (336)
- Health Economics (612)
- Health Informatics (2287)
- Health Policy (910)
- Hematology (333)
- HIV/AIDS (742)
- Medical Education (357)
- Medical Ethics (100)
- Nephrology (385)
- Neurology (3326)
- Nursing (190)
- Nutrition (504)
- Oncology (1748)
- Ophthalmology (522)
- Orthopedics (208)
- Otolaryngology (283)
- Pain Medicine (222)
- Palliative Medicine (66)
- Pathology (435)
- Pediatrics (998)
- Primary Care Research (399)
- Public and Global Health (5974)
- Radiology and Imaging (1216)
- Respiratory Medicine (807)
- Rheumatology (367)
- Sports Medicine (311)
- Surgery (383)
- Toxicology (50)
- Transplantation (170)
- Urology (142)